Although others have explored the prognostic value of SerpinB2 in BC patients, the status of SerpinB2 from tumor extracts was evaluated using RT-PCR and immunoenzymatic assays, which do not discriminate between cancer and stromal cells that also express SerpinB2 [16, 20, 36–40]. Here, SERPINB2 is linked to cancer.